The Current Ratio as of November 2024 (TTM) for Lumos Pharma, Inc. (LUMO) is 4.23

According to Lumos Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.23. This represents a change of -29.23% compared to the average of 5.98 of the last 4 quarters.

Lumos Pharma, Inc. (LUMO) Historical Current Ratio (quarterly & annually)

How has LUMO Current Ratio performed in the past?

The mean historical Current Ratio of Lumos Pharma, Inc. over the last ten years is 11.37. The current 4.23 Current Ratio has changed 3.62% with respect to the historical average. Over the past ten years (40 quarters), LUMO's Current Ratio was at its highest in in the June 2015 quarter at 25.95. The Current Ratio was at its lowest in in the March 2020 quarter at 1.99.

Lumos Pharma, Inc. (LUMO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lumos Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lumos Pharma, Inc. (LUMO) Average Current Ratio

How has LUMO Current Ratio performed in the past?

The current Current Ratio of Lumos Pharma, Inc. (LUMO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lumos Pharma, Inc. (LUMO) Current Ratio vs. Peers

How is LUMO’s Current Ratio compared to its peers?

Lumos Pharma, Inc.’s Current Ratio is less than Pardes Biosciences, Inc. (0), less than Shattuck Labs, Inc. (81.72), less than Eliem Therapeutics, Inc. (7.62), less than Champions Oncology, Inc. (60.41), greater than Century Therapeutics, Inc. (0.69), less than Silo Pharma, Inc. (10.62), less than Protagenic Therapeutics, Inc. (5.84), greater than Rezolute, Inc. (2.03), less than Anebulo Pharmaceuticals, Inc. (13.39), less than ZIVO Bioscience, Inc. (13.46), greater than Theseus Pharmaceuticals, Inc. (0.17), less than Erasca, Inc. (29.93), less than Forte Biosciences, Inc. (16.79), greater than Applied Molecular Transport Inc. (2.82), less than null (4.99),

Build a custom stock screener for Lumos Pharma, Inc. (LUMO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lumos Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lumos Pharma, Inc. (LUMO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lumos Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.